1h Free Analyst Time
The publisher has been monitoring the cardiac monitoring and cardiac rhythm management devices market and it is poised to grow by $ 5.52 bn during 2022-2026, accelerating at a CAGR of 4.5% during the forecast period. The report on the cardiac monitoring and cardiac rhythm management devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of CVDs, technological advances, and the increasing uptake of mobile cardiac telemetry (MCT).
The cardiac monitoring and cardiac rhythm management devices market analysis includes product segment and geographic landscape.
The analyst's cardiac monitoring and cardiac rhythm management devices market is segmented as below:
By Product:
- Cardiac rhythm management devices
- Cardiac monitoring devices
By Geographical Landscape:
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the increasing r&d focus as one of the prime reasons driving the cardiac monitoring and cardiac rhythm management devices market growth during the next few years. Also, the growing focus on the development of integrated arrhythmia monitoring devices and increasing utilization of cardiac implants will lead to sizable demand in the market.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. The report on the cardiac monitoring and cardiac rhythm management devices market covers the following areas:
- Cardiac monitoring and cardiac rhythm management devices market sizing
- Cardiac monitoring and cardiac rhythm management devices market forecast
- Cardiac monitoring and cardiac rhythm management devices market industry analysis
The analyst's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cardiac monitoring and cardiac rhythm management devices market vendors that include Abbott Laboratories, Abiomed Inc., ACS Diagnostics Inc., Asahi Kasei Corp., BioTelemetry Inc., BIOTRONIK SE, and Co KG, Boston Scientific Corp., Fukuda Denshi Co. Ltd., GE Healthcare Inc., HILL ROM HOLDINGS Inc., InfoBionic Inc., Integrated Sensing Systems Inc., iRhythm Technologies Inc., Koninklijke Philips NV, Medtronic Plc, MicroPort Scientific Corp., Nihon Kohden Corp., OSI Systems Inc., Preventice Solutions Inc., and SCHILLER AG. Also, the cardiac monitoring and cardiac rhythm management devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The analyst's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Product
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global cardiac monitoring and cardiac rhythm management devices market: Abbott Laboratories, Abiomed Inc., ACS Diagnostics Inc., Asahi Kasei Corp., BioTelemetry Inc., BIOTRONIK SE, and Co KG, Boston Scientific Corp., Fukuda Denshi Co. Ltd., GE Healthcare Inc., HILL ROM HOLDINGS Inc., InfoBionic Inc., Integrated Sensing Systems Inc., iRhythm Technologies Inc., Koninklijke Philips NV, Medtronic Plc, MicroPort Scientific Corp., Nihon Kohden Corp., OSI Systems Inc., Preventice Solutions Inc., and SCHILLER AG.Commenting on the report, an analyst said: "The latest trend gaining momentum in the market is increasing r&d focus."
According to the report , one of the major drivers for this market is the increasing prevalence of CVDs.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abiomed Inc.
- ACS Diagnostics Inc.
- Asahi Kasei Corp.
- BioTelemetry Inc.
- BIOTRONIK SE and Co KG
- Boston Scientific Corp.
- Fukuda Denshi Co. Ltd.
- GE Healthcare Inc.
- HILL ROM Holdings Inc.
- InfoBionic Inc.
- Integrated Sensing Systems Inc.
- iRhythm Technologies Inc.
- Koninklijke Philips NV
- Medtronic Plc
- MicroPort Scientific Corp.
- Nihon Kohden Corp.
- OSI Systems Inc.
- Preventice Solutions Inc.
- SCHILLER AG
